Neurosense Therapeutics (NRSN) Financials

$0.42

$-0.09 (-18.15%)

As on 08-Sep-2026 16:17EDT

Market cap

$19 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.6

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-7.67	-10.14	-8.35	-7.59	-1.54	-0.70
Cash Flow from Investing Activities	-0.01	0.00	3.47	-3.54	-0.02	-0.01
Cash from Financing Activities	4.43	10.91	3.98	3.70	11.90	0.51
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-0.44	-0.44	-0.66	-1.05	-0.37	-0.51
Cash EPS ($)	-0.43	-0.44	-0.65	-1.04	-0.37	-0.51
Adjusted Book Value ($)	--	0.11	--	0.48	0.82	0.12
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.30	-0.44	-0.54	-0.64	-0.14	-0.12
Free Cash Flow per Share ($)	-0.30	-0.44	-0.55	-0.65	-0.14	-0.13

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	-1,757.50	-1,965.35	-479.80	-148.10	-70.32	-358.66
ROE (%)	-2,174.98	-2,478.16	-523.68	-168.75	-83.62	-358.66
ROA (%)	-397.11	-263.14	-185.53	-128.94	-66.19	-326.18
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-12.39	-2.48	21.59	-326.67	-2.09	-13.67
Net Profit Growth (%)	-8.96	-1.02	18.10	-205.37	-42.89	-130.48
EPS Growth (%)	0.01	0.33	0.37	-1.84	0.27	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	-1.77	-2.73	-1.19	-1.16	-6.66	--
Price / Book Value	-12.60	10.79	-6.86	2.56	2.99	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.77	-2.49	-0.99	-0.61	-6.13	--
Close Price ($)	0.77	1.20	0.79	1.22	2.46	--
High Price ($)	2.60	2.33	2.91	8.18	4.70	--
Low Price ($)	0.68	0.51	0.40	1.15	2.39	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	-0.11	0.03	-0.08	0.04	0.20	--
Short term debt to equity ratio	-0.06	0.03	-0.04	0.01	--	--
Current Ratio	0.31	2.21	0.84	4.28	19.12	6.08
Quick Ratio	--	--	--	6.41	19.41	6.08
Interest Coverage	--	-31.83	-17.56	-821.20	-2.50	-2,828.00

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	-13,849.38	-7,912.38	-10,839.83	-5.17
Payable days	--	21,740.68	3,684.51	1,101.91	5,722.25	4,748.25
Cash Conversion Cycle	--	--	--	--	--	--